Kisqali 400 MG daily dose 42S
Ended Awarded
- Contract number
- SPE2DR26FXQ1D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,663
Award facts
- Contract value 100% obligated
- $16,663.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,663.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Kisqali 400 mg daily dose in a quantity of 42 units. The contract, which is a non-set-aside competitive award, is scheduled for completion by December 8, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Kisqali is a prescription medication used in cancer treatment, reflecting the Defense Logistics Agency's medical supply procurement needs for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen Drug Corp maintains an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The company's competitively awarded contracts with the Defense Logistics Agency demonstrate its established capability to fulfill federal procurement requirements for military and defense healthcare operations on a global scale.
Quick answers
Who was awarded contract SPE2DR26FXQ1D?
SPE2DR26FXQ1D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 14, 2025.
How much is contract SPE2DR26FXQ1D worth?
The government has obligated $16,663 on SPE2DR26FXQ1D.
Is contract SPE2DR26FXQ1D an order under another contract?
Yes. SPE2DR26FXQ1D is a delivery order under SPE2DR25D6029, an indefinite delivery contract.
Was contract SPE2DR26FXQ1D competed?
The extent of competition for SPE2DR26FXQ1D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award